| 2024 |
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD)
10.1136/lupus-2024-001213
Authors: J. Ellis, N. McHugh, J. Pauling, I. Bruce, R. Charlton, A. McGrogan, S. Skeoch |
| 2024 |
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
10.1186/s12931-024-02875-2
Authors: B. Ozaltin, R. Chapman, M. Arfeen, N. Fitzpatick, H. Hemingway, K. Direk, J. Jacob |
| 2024 |
Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study
10.1136/thorax-2023-221210
Authors: D. Lo, C. Lawson, C. Gillies, S. Shabnam, E. Gaillard, H. Pinnock, J. Quint |
| 2024 |
Enhancing recruitment of individuals living with frailty, multimorbidity and cognitive impairment to Parkinson's research: experiences from the PRIME-UK cross-sectional study
10.1093/ageing/afae108
Authors: E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson |
| 2024 |
A New Validated Approach for Identifying Childhood Immunizations in Electronic Health Records in the United Kingdom
10.1002/pds.5848
Authors: A. Suffel, J. Walker, C. Campbell, H. Carreira, C. Warren-Gash, H. McDonald |
| 2024 |
Cardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)
10.1093/aje/kwae137
Authors: P. Baptiste, A. Wong, A. Schultze, C. Clase, C. Leyrat, E. Williamson, E. Powell, J. Mann, M. Cunnington, K. Teo, S. Bangdiwala, P. Gao, L. Tomlinson, K. Wing |
| 2024 |
Clinical and economic burden of severe asthma with low blood eosinophil counts
10.1016/j.jaip.2024.07.010
Authors: J. Busby, S. Menon, N. Martin, J. Lipworth, R. Zhang, H. Burhan, T. Brown, R. Chaudhuri, R. Gore, D. Jackson, S. Naveed, T. Pantin, P. Pfeffer, M. Patel, P. Patel, H. Rupani, L. Heaney |
| 2024 |
Overcoming Time-Varying Confounding in Self-Controlled Case Series with Active Comparators: Application and Recommendations
10.1093/aje/kwae216
Authors: A. Schultze, J. Brown, J. Logie, M. Cunnington, G. Requena, I. Gillespie, S. Evans, I. Douglas, N. Galwey |
| 2024 |
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study
10.1136/bmj-2023-078523
Authors: N. Conrad, G. Molenberghs, G. Verbeke, F. Zaccardi, C. Lawson, J. Friday, H. Su, P. Jhund, N. Sattar, K. Rahimi, J. Cleland, K. Khunti, W. Budts, J. McMurray |
| 2024 |
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study
10.1002/ehf2.14981
Authors: C. Ju, W. C. Y. Lau, C. Manisty, P. Chambers, R. Brauer, M. Forster, I. Mackenzie, L. Wei |
| 2024 |
Comparison of oral anticoagulants for stroke prevention in atrial fibrillation using the UK clinical practice research Datalink Aurum: A reference trial (ARISTOTLE) emulation study
10.1371/journal.pmed.1004377
Authors: E. Powell, U. Gungabissoon, J. Tazare, L. Smeeth, P. Baptiste, T. Bin Hammad, A. Wong, I. Douglas, K. Wing |
| 2024 |
Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021
10.1136/bmjresp-2023-002273
Authors: A. Ioannides, A. Morgan, J. Quint |
| 2024 |
Incidence, antimicrobial prescribing practice and associated healthcare costs of paediatric otorrhoea in primary care in the UK: A longitudinal population study
10.3399/bjgp.2024.0053
Authors: E. Heward, E. Domzaridou, S. Gavan, M. Carr, J. Lunn, J. Molloy, R. Isba, A. Hay, J. Nichani, I. Bruce, D. Ashcroft |
| 2024 |
UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications
10.2147/por.s469973
Authors: G. Massen, O. Blamires, M. Grainger, M. Matta, R. Twumasi, T. Joshi, A. Laity, E. Nakariakova, T. Thavaranjan, A. Sheikh, J. Quint |
| 2024 |
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users
10.1111/bcp.16190
Authors: D. Iversen, A. Dunvald, M. Ernst, S. Abtahi, P. Souverein, O. Klungel, G. Jeppesen, F. Nielsen, K. Brøsen, H. Hammer, O. Pötz, P. Damkier, E. Järvinen, A. Pottegard, T. Stage |
| 2024 |
Prevalence, risk factors and characterisation of individuals with long COVID using Electronic Health Records in over 1.5 million COVID cases in England
10.1016/j.jinf.2024.106235
Authors: H. Wang, T. Doran, M. Crooks, K. Khunti, M. Heightman, A. Gonzalez-Izquierdo, Qummer Arfeen, A. Loveless, A. Banerjee, C. Van Der Feltz-Cornelis |
| 2024 |
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions
10.1093/eurjpc/zwae174
Authors: LIFE-CVD2 Group |
| 2024 |
An international study to investigate and optimise the safety of discontinuing valproate in young men and women with epilepsy: Protocol
10.1371/journal.pone.0306226
Authors: G. Mbizvo, G. Martin, M. Sperrin, L. Bonnett, P. Schofield, I. Buchan, G. Lip, A. Marson |
| 2024 |
Foundational model aided automatic high-throughput drug screening using self-controlled cohort study
10.1101/2024.08.04.24311480
Authors: S. Xu, R. Cobzaru, S. Finkelstein, R. Welsch, K. Ng, L. Middleton |
| 2024 |
The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England
10.1093/infdis/jiad420
Authors: S. Kujawski, V. Banks, C. Casey, S. Drysdale, A. Patel, O. Massey, T. Holbrook, M. Pawaskar |
| 2024 |
Risk of fibromyalgia following antibiotic prescriptions: A population-based case-control study
10.1002/ejp.2239
Authors: D. Armstrong, A. Dregan, M. Ashworth, P. White |
| 2024 |
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort
10.34067/kid.0000000000000468
Authors: S. Fishbane, J. Carrero, S. Kumar, E. Kanda, K. Hedman, R. Ofori-Asenso, N. Kashihara, M. Kosiborod, M. Lainscak, C. Pollock, P. Stenvinkel, D. Wheeler, R. Pecoits-Filho |
| 2024 |
Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study
10.1016/j.vaccine.2023.11.063
Authors: H. Skirrow, K. Foley, H. Bedford, C. Lewis, E. Whittaker, C. Costelloe, S. Saxena |
| 2024 |
Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events
10.1164/rccm.202402-0368OC
Authors: C. Bloom, F. Yang, R. Hubbard, A. Majeed, J. Wedzicha |
| 2024 |
Rising incidence, health resource utilization and costs of Polycystic Ovary Syndrome in the United Kingdom
10.1210/clinem/dgae518
Authors: T. Berni, C. Morgan, D. Rees |
| 2024 |
Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink
10.1002/clc.24297
Authors: S. Kiddle, K. Sundell, S. Perl, S. Nolan, M. Bjursell |
| 2024 |
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study
10.1136/thorax-2023-220259
Authors: A. Wilkinson, E. Maslova, C. Janson, V. Radhakrishnan, J. Quint, N. Budgen, T. Tran, Y. Xu, A. Menzies-Gow, J. Bell |
| 2024 |
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study
10.1161/strokeaha.123.045098
Authors: R. Chiv, S. Beradid, S. Suissa, C. Renoux |
| 2024 |
Effect of timeframes to define long term conditions and sociodemographic factors on prevalence of multimorbidity using disease code frequency in primary care electronic health records: retrospective study
10.1136/bmjmed-2022-000474
Authors: T. Beaney, J. Clarke, T. Woodcock, A. Majeed, M. Barahona, P. Aylin |
| 2024 |
Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals
10.1136/bmjopen-2023-077156
Authors: N. Gunathilaka, T. Gooden, J. Cooper, S. Flanagan, T. Marshall, S. Haroon, A. D'Elia, F. Crowe, T. Jackson, K. Nirantharakumar, S. Greenfield |
| 2024 |
Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD)
10.1136/bmjopen-2023-072026
Authors: J. Robinson, R. Martin, M. Ozawa, M. Elwenspoek, M. Redaniel, K. Kurian, Y. Ben-Shlomo |
| 2024 |
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls
10.1016/s2665-9913(23)00338-7
Authors: L. Ferguson, G. Molenberghs, G. Verbeke, K. Rahimi, S. Rao, I. McInnes, J. McMurray, N. Sattar, N. Conrad |
| 2024 |
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study
10.1136/bmjopen-2023-072361
Authors: A. Czira, V. Banks, G. Requena, R. Wood, T. Tritton, R. Wild, C. Compton, A. Ismaila |
| 2024 |
Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma
10.1080/03007995.2024.2322048
Authors: M. Cordeiro, P. Denis, C. Astarita, J. Belsey, M. Rivas, J. García-Feijoo |
| 2024 |
Population-based study of alcohol-related liver disease in England 2001-2018: Influence of socioeconomic position
10.14309/ajg.0000000000002677
Authors: G. Askgaard, P. Jepsen, M. Jensen, A. Kann, J. Morling, F. Kraglund, T. Card, C. Crooks, J. West |
| 2024 |
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study
10.1097/inf.0000000000004213
Authors: J. Yang, K. Andersen, K. Rai, T. Tritton, T. Mugwagwa, C. Tsang, M. Reimbaeva, L. McGrath, P. Payne, B. Backhouse, D. Mendes, R. Butfield, R. Wood, J. Nguyen |
| 2024 |
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data
10.1016/j.diabres.2024.111641
Authors: I. Carey, J. Critchley, A. U, D. Cook, S. DeWilde, E. Limb, L. Bowen, S. Woolford, P. Whincup, N. Sattar, A. Panahloo, T. Harris |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
10.1136/rmdopen-2023-003980
Authors: A. Abhishek, M. Grainge, T. Card, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, M. Stevenson, G. Nakafero, R. Riley |
| 2024 |
Standardizing to Specific Target Populations in Distributed Networks and Multi-Site Pharmacoepidemiologic Studies
10.1093/aje/kwae015
Authors: M. Webster-Clark, K. Filion, R. Platt |
| 2024 |
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
10.1016/j.ijid.2024.01.002
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
10.1093/ehjcvp/pvae022
Authors: T. Eroglu, R. Coronel, P. Souverein |
| 2024 |
Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study
10.1016/j.canep.2024.102552
Authors: C. Cardwell, R. McDowell, C. Hughes, J. Busby, P. Murchie |
| 2024 |
Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study
10.1016/s2468-2667(24)00028-8
Authors: A. Head, M. Birkett, K. Fleming, C. Kypridemos, M. O'Flaherty |
| 2024 |
Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study
10.1093/rheumatology/keae160
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek |
| 2024 |
Comparing the clinical practice and prescribing safety of locum and permanent doctors: observational study of primary care consultations in England
10.1186/s12916-024-03332-z
Authors: C. Grigoroglou, K. Walshe, E. Kontopantelis, J. Ferguson, G. Stringer, D. Ashcroft, T. Allen |
| 2024 |
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
10.1093/bjd/ljae133
Authors: V. Eleftheriadou, C. Delattre, S. Chetty-Mhlanga, C. Lee, L. Girardat-Rotar, I. Khan, A. Mathew, A. Thompson |
| 2024 |
Post-hospitalisation asthma management in primary care: a retrospective cohort study
10.3399/bjgp.2023.0214
Authors: D. Punyadasa, N. Simms-Williams, N. Adderley, R. Thayakaran, A. Mansur, K. Nirantharakumar, P. Nagakumar, S. Haroon |
| 2024 |
Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021
10.1007/s00415-023-12165-4
Authors: R. Shankar, X. Marston, V. Danielson, Do Rego, R. Lasagne, O. Williams, L. Groves |
| 2024 |
Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years
10.1186/s12875-023-02242-y
Authors: D. Kernick, N. Kondori, A. Pain, J. Mount, C. Appel, M. Ranopa, T. Gulati |
